blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1643980

EP1643980 - DRY POWDER FOR INHALATION COMPRISING A FORMOTEROL SALT AND CICLESONIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.05.2014
Database last updated on 13.11.2024
Most recent event   Tooltip24.07.2015Lapse of the patent in a contracting state
New state(s): BG, HU, LU		published on 26.08.2015  [2015/35]
Applicant(s)For all designated states
Takeda GmbH
Byk-Gulden-Strasse 2
78467 Konstanz / DE
[2013/24]
Former [2009/23]For all designated states
Nycomed GmbH
Byk-Gulden-Strasse 2
78467 Konstanz / DE
Former [2006/15]For all designated states
Aventis Pharma Limited
Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling
Kent ME19 4AH / GB
Inventor(s)01 / WAYLAND, Ruth, Margaret
33 Crewe Road
Nantwich, Cheshire CW5 6HX / GB
 [2006/15]
Representative(s)Adamson Jones
Park View House
58 The Ropewalk
Nottingham NG1 5DW / GB
[N/P]
Former [2013/27]Adamson Jones
BioCity Nottingham Pennyfoot Street Nottingham
Nottinghamshire NG1 1GF / GB
Former [2009/27]Adamson Jones
BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF / GB
Former [2006/15]Jones, Stephen Anthony
AdamsonJones BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF / GB
Application number, filing date04743295.008.07.2004
[2006/15]
WO2004GB02953
Priority number, dateGB2003001588908.07.2003         Original published format: GB 0315889
[2006/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005004853
Date:20.01.2005
Language:EN
[2005/03]
Type: A1 Application with search report 
No.:EP1643980
Date:12.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 20.01.2005 takes the place of the publication of the European patent application.
[2006/15]
Type: B1 Patent specification 
No.:EP1643980
Date:03.07.2013
Language:EN
[2013/27]
Search report(s)International search report - published on:EP20.01.2005
ClassificationIPC:A61K9/72, A61K31/167, A61K31/573
[2006/15]
CPC:
A61K9/0075 (EP,US); A61K31/167 (EP,US); A61K31/573 (EP,US);
A61P11/06 (EP); A61P11/08 (EP); A61P9/00 (EP)
C-Set:
A61K31/167, A61K2300/00 (EP,US);
A61K31/573, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/15]
TitleGerman:TROCKENPULVER ZUR INHALATION MIT EINEM FORMOTEROLSALZ UND CICLESONID[2006/15]
English:DRY POWDER FOR INHALATION COMPRISING A FORMOTEROL SALT AND CICLESONIDE[2006/15]
French:POUDRE SECHE POUR INHALATION COMPRENANT UN SEL FORMOTEROL ET DU CICLESONIDE[2006/15]
Entry into regional phase24.12.2005National basic fee paid 
24.12.2005Designation fee(s) paid 
24.12.2005Examination fee paid 
Examination procedure05.04.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.12.2005Amendment by applicant (claims and/or description)
24.12.2005Examination requested  [2006/15]
13.12.2007Despatch of a communication from the examining division (Time limit: M06)
16.09.2008Reply to a communication from the examining division
22.10.2008Despatch of a communication from the examining division (Time limit: M08)
05.08.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.09.2009Reply to a communication from the examining division
09.12.2011Despatch of a communication from the examining division (Time limit: M06)
18.06.2012Reply to a communication from the examining division
19.09.2012Communication of intention to grant the patent
07.01.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
24.01.2013Communication of intention to grant the patent
14.05.2013Fee for grant paid
14.05.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.12.2007
Opposition(s)04.04.2014No opposition filed within time limit [2014/24]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
16.09.2008Request for further processing filed
16.09.2008Full payment received (date of receipt of payment)
Request granted
30.09.2008Decision despatched
Fees paidRenewal fee
27.07.2006Renewal fee patent year 03
14.08.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
10.07.2009Renewal fee patent year 06
14.07.2010Renewal fee patent year 07
12.07.2011Renewal fee patent year 08
13.07.2012Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.07.200704   M06   Fee paid on   14.08.2007
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.07.2004
AT03.07.2013
BE03.07.2013
BG03.07.2013
CY03.07.2013
CZ03.07.2013
DK03.07.2013
EE03.07.2013
FI03.07.2013
MC03.07.2013
NL03.07.2013
PL03.07.2013
RO03.07.2013
SE03.07.2013
SI03.07.2013
SK03.07.2013
TR03.07.2013
IE08.07.2013
LU08.07.2013
GR04.10.2013
PT04.11.2013
[2015/34]
Former [2015/32]AT03.07.2013
BE03.07.2013
CY03.07.2013
CZ03.07.2013
DK03.07.2013
EE03.07.2013
FI03.07.2013
MC03.07.2013
NL03.07.2013
PL03.07.2013
RO03.07.2013
SE03.07.2013
SI03.07.2013
SK03.07.2013
TR03.07.2013
IE08.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/33]AT03.07.2013
BE03.07.2013
CY03.07.2013
CZ03.07.2013
DK03.07.2013
EE03.07.2013
FI03.07.2013
MC03.07.2013
NL03.07.2013
PL03.07.2013
RO03.07.2013
SE03.07.2013
SI03.07.2013
SK03.07.2013
IE08.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/23]AT03.07.2013
BE03.07.2013
CY03.07.2013
CZ03.07.2013
DK03.07.2013
EE03.07.2013
FI03.07.2013
MC03.07.2013
NL03.07.2013
PL03.07.2013
RO03.07.2013
SE03.07.2013
SI03.07.2013
SK03.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/22]AT03.07.2013
BE03.07.2013
CY03.07.2013
DK03.07.2013
FI03.07.2013
MC03.07.2013
NL03.07.2013
PL03.07.2013
RO03.07.2013
SE03.07.2013
SI03.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/21]AT03.07.2013
BE03.07.2013
CY03.07.2013
DK03.07.2013
FI03.07.2013
MC03.07.2013
NL03.07.2013
PL03.07.2013
SE03.07.2013
SI03.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/20]AT03.07.2013
BE03.07.2013
CY03.07.2013
FI03.07.2013
MC03.07.2013
NL03.07.2013
PL03.07.2013
SE03.07.2013
SI03.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/18]AT03.07.2013
BE03.07.2013
CY03.07.2013
FI03.07.2013
NL03.07.2013
PL03.07.2013
SE03.07.2013
SI03.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/14]AT03.07.2013
BE03.07.2013
FI03.07.2013
NL03.07.2013
PL03.07.2013
SE03.07.2013
SI03.07.2013
CY10.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/12]AT03.07.2013
BE03.07.2013
FI03.07.2013
PL03.07.2013
SE03.07.2013
SI03.07.2013
CY10.07.2013
GR04.10.2013
PT04.11.2013
Former [2014/11]AT03.07.2013
BE03.07.2013
FI03.07.2013
PL03.07.2013
SE03.07.2013
SI03.07.2013
CY10.07.2013
PT04.11.2013
Former [2014/10]AT03.07.2013
BE03.07.2013
SE03.07.2013
SI03.07.2013
CY10.07.2013
PT04.11.2013
Former [2014/09]AT03.07.2013
BE03.07.2013
SE03.07.2013
SI03.07.2013
PT04.11.2013
Former [2014/08]SI03.07.2013
PT04.11.2013
Former [2013/49]SI03.07.2013
Cited inInternational search[A]DE19541689  (BYK GULDEN LOMBERG CHEM FAB [DE]) [A] 1-83 * example 4 *;
 [A]WO0028979  (SKYEPHARMA AG [CH], et al) [A] 1-83 * page 2, line 16 - line 20 * * page 14, line 14 - line 20 *;
 [A]WO0189616  (GLAXO GROUP LTD [GB], et al) [A] 1-83 * page 8, line 1 - line 12 *;
 [A]WO0228368  (ORION CORP [FI], et al) [A] 1-83 * page 2, line 8 - line 13 * * page 8, line 6 - line 14 * * claims 1-11 *;
 [A]US6475467  (KELLER MANFRED [DE], et al) [A] 1-83 * examples 11,12 * * claim 10 *;
 [A]  - KIRSCH L ET AL, "DEVELOPMENT OF A LYOPHILIZED FORMULATION FOR (R,R)-FORMOTEROL (L)-TARTRATE", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, NEW YORK, NY, US, (2001), vol. 27, no. 1, ISSN 0363-9045, pages 89 - 96, XP001091202 [A] 1-83 * abstract *

DOI:   http://dx.doi.org/10.1081/DDC-100000132
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.